Intravenous Pertussis Immune Globulin in Patients With Severe Childhood Pertussis Infection
Assess the efficacy of a single infusion of a high titer pertussis immune globulin for the treatment of severe pertussis in children.
|Study Design:||Allocation: Randomized
Primary Purpose: Treatment
|Study Start Date:||August 1997|
|Estimated Study Completion Date:||September 2002|
PROTOCOL OUTLINE: This is a randomized, multicenter study. Patients are randomized to receive an infusion of either pertussis immune globulin or placebo (0.9% saline).
Patients are followed every 2 weeks for up to 6 months.
Completion date provided represents the completion date of the grant per OOPD records
Please refer to this study by its ClinicalTrials.gov identifier: NCT00004422
|Study Chair:||Scott A. Halperin||IWK Health Centre|